Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Novel tachykinin NK1 antagonists disclosed in recent Merck & Co. patent

Jan. 27, 2006

New IP receptor antagonists from Roche show analgesic potential

Jan. 27, 2006

Orphan drug status for Myodur in Duchenne and Becker muscular dystrophies

Jan. 27, 2006

Orphan drug designation for ACR-16 for Huntington's disease

Jan. 27, 2006

NEPP compounds provide neuroprotection via modulation of Keap1/Nrf2 to activate HO-1

Jan. 27, 2006

Posiphen completes first phase I study for Alzheimer's disease progression

Jan. 26, 2006

Eurand inlicenses novel analgesic compounds from Italian universities

Jan. 26, 2006

Promising preclinical results in Duchenne muscular dystrophy at VASTox

Jan. 26, 2006

Recent patents cover therapeutic agents for neurological disorders

Jan. 25, 2006

Dyloject relieves postoperative pain faster than ketorolac in phase IIb study

Jan. 25, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...